Thrivent Financial For Lutherans Adma Biologics, Inc. Transaction History
Thrivent Financial For Lutherans
- $45.7 Billion
- Q2 2025
A detailed history of Thrivent Financial For Lutherans transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 3,315,425 shares of ADMA stock, worth $48.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,315,425
Previous 1,861,501
78.1%
Holding current value
$48.2 Million
Previous $36.9 Million
63.47%
% of portfolio
0.13%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$311 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$271 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...